The Evolution of Patient Technology in Cancer Clinical Research
Although the pandemic initially added to the challenges oncology clinical trials and the patients in them faced, it also helped to accelerate the collaboration of regulatory agencies, pharma companies, CROs and technology providers to implement solutions that improve the patient experience. In this white paper, we will:
- Explore cancer patients' historical reluctance to participate;
- Review oncology clinical research and market dynamics; and,
- Identify trends and technology to improve cancer clinical research in 2022 and beyond.